What is DMP.DE's gross margin?

Dermapharm (DMP.DE) has a gross margin of 33% and a net margin of 8%.

What is DMP.DE's P/E ratio?

DMP.DE's P/E ratio is 13.5 with ROE of 26%.

Where can I see DMP.DE's full financials?

See Dermapharm (DMP.DE) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Dermapharm (DMP.DE) Financials — Revenue, Earnings, Cash Flow

Also trades as: 52D0.F (FSX) · $vol 0M · DMPHF (OTC) · $vol 0M

€37.50 ($42.05)

-0.95 (-2.47%)

Weekly Expected Move ±3.3%

€35 €36 €38 €39 €40

XETRA · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · €1.9B mcap · 11M float · 0.272% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

€1B

Revenue

+0.4% YoY

€147M

Net Income

+36.7% YoY

€171M

Free Cash Flow

-2.2% YoY

33.4%

Gross Margin

24.9%

Op. Margin

8.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE25.6%

ROA6.7%

ROIC13.0%

Valuation

P/E13.5

P/B3.5

EV/EBITDA9.8

Leverage

Debt/Equity2.18

Current Ratio1.71

Interest Cov.5.4x

Quality Scores

Piotroski F5/9

Altman Z2.14

Beneish M-1.94